Andrew L. Reynolds
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrew L. Reynolds has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Margaret M. DeAngelis
Department of Ophthalmology, Ross Eye Institute, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, USA
4 shared publications - Leah A. Owen
John A. Moran Eye Center, Department of Ophthalmology and Visual Sciences, University of Utah, Salt Lake City, USA
3 shared publications - Patrice M. Hicks
Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI 48105, USA
3 shared publications Andrew Beiter
Department of Ophthalmology, West Virginia University Eye Institute, Morgantown, USA
2 shared publicationsCharles Zhang
Department of Ophthalmology, Ross Eye Institute, Buffalo, USA
2 shared publications- Elizabeth Au
Department of Ophthalmology, Ross Eye Institute, Jacobs School of Medicine and Biomedical Sciences, State University of New York, University at Buffalo, Buffalo, NY 14203, USA
2 shared publications
Latest Publications
- Open Access
- 19 May 2025
- Published by Springer Nature in Cureus
- Vol. 17 (5) , e84417
The Effect of Allergic Conjunctivitis on Refractive Error in the Pediatric Population
Introduction Refractive error is one of the most common causes of visual impairment in the world, negatively affecting a patient’s quality of life, economic opportunities and more. Although numerous studies have explored the impact of severe ocular allergies on refractive error, there is limited research on how relatively mild forms of ocular allergies may affect vision. This study aims to assess the impact of allergic conjunctivitis, a milder and more common ocular allergy, on the development and progression of refractive error in the pediatric population. Methods This was a retrospective study that reviewed the records (2015-2018) of 198 established pediatric patients from the Ross Eye Institute: 90 with a new diagnosis of allergic conjunctivitis, and 108 age- and sex-matched controls. All refractions were performed by a single board-certified and fellowship-trained pediatric ophthalmologist utilizing retinoscopy, the gold standard for measuring refractive error in the pediatric population. T-tests were used to analyze continuous variables, and chi-square tests were used for categorical variables. Linear regression was used to identify factors associated with refractive error. Results The average age of the patient population was 9.7 years, with 42% males. Children with allergic conjunctivitis were found to have a significantly higher incidence of cylindrical refractive error compared to controls (56% vs 34%, p < 0.001), with increased cylindrical power (1.20 ± 0.07 D vs 0.80 ± 0.08 D; p < 0.001), but no difference in spherical equivalent (-0.83 ± 0.27 vs -0.66 ± 0.21, p = 0.64). Additionally, compared to the refraction obtained one year prior to the diagnosis of allergic conjunctivitis, patients were found to have a greater increase in cylindrical power compared to controls (0.13 ± 0.04 D vs 0.01 ± 0.02 D, p = 0.007), with no significant difference in the type of cylindrical refractive error. Conclusions Our study demonstrates that allergic conjunctivitis may prognosticate the development and progression of cylindrical refractive error in children.
- 19 May 2025
- Published by Springer Nature in Cureus
- Vol. 17 (5) , e84417
Open AccessThe Effect of Allergic Conjunctivitis on Refractive Error in the Pediatric Population
Introduction Refractive error is one of the most common causes of visual impairment in the world, negatively affecting a patient’s quality of life, economic opportunities and more. Although numerous studies have explored the impact of severe ocular allergies on refractive error, there is limited research on how relatively mild forms of ocular allergies may affect vision. This study aims to assess the impact of allergic conjunctivitis, a milder and more common ocular allergy, on the development and progression of refractive error in the pediatric population. Methods This was a retrospective study that reviewed the records (2015-2018) of 198 established pediatric patients from the Ross Eye Institute: 90 with a new diagnosis of allergic conjunctivitis, and 108 age- and sex-matched controls. All refractions were performed by a single board-certified and fellowship-trained pediatric ophthalmologist utilizing retinoscopy, the gold standard for measuring refractive error in the pediatric population. T-tests were used to analyze continuous variables, and chi-square tests were used for categorical variables. Linear regression was used to identify factors associated with refractive error. Results The average age of the patient population was 9.7 years, with 42% males. Children with allergic conjunctivitis were found to have a significantly higher incidence of cylindrical refractive error compared to controls (56% vs 34%, p < 0.001), with increased cylindrical power (1.20 ± 0.07 D vs 0.80 ± 0.08 D; p < 0.001), but no difference in spherical equivalent (-0.83 ± 0.27 vs -0.66 ± 0.21, p = 0.64). Additionally, compared to the refraction obtained one year prior to the diagnosis of allergic conjunctivitis, patients were found to have a greater increase in cylindrical power compared to controls (0.13 ± 0.04 D vs 0.01 ± 0.02 D, p = 0.007), with no significant difference in the type of cylindrical refractive error. Conclusions Our study demonstrates that allergic conjunctivitis may prognosticate the development and progression of cylindrical refractive error in children.
- Open Access
- 24 May 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (11) , 3071
Clinical Outcomes in Scleral Fixation Secondary Intraocular Lens with Yamane versus Suture Techniques: A Systematic Review and Meta-Analysis
Background: The purpose of the study is to compare the visual outcomes and complications of sutured scleral fixation (SSF), a traditional and conservative surgical approach, and the newer and faster Yamane technique for secondary intraocular lens placement. Methods: A literature search was performed on PubMed, Embase, and Scopus on studies published between 1 July 2017 to 29 September 2023. Outcomes analyzed included the final best corrected visual acuity (BCVA) between 3 and 12 months to assess the effectiveness of the procedure, post-operative month (POM) 1 BCVA to assess the speed of visual recovery, endothelial cell count (ECC), absolute refractive error, surgical duration, and complication rates. Additional subgroup analyses were performed based on surgeon experience with the technique. Single-surgeon studies had an average of 26 procedures performed, whereas multiple-surgeon studies averaged only 9 procedures performed; these were then used to delineate surgeon experience. A sample-size weighted mean difference (MD) meta-analysis was performed across all variables using RevMan 5.4.1; p < 0.05 was considered statistically significant. Results: Thirteen studies with 737 eyes were included: 406 eyes were included in the SSF group, and 331 eyes were included in the Yamane group. There was no significant difference in the final BCVA between groups in both the single-surgeon versus multiple-surgeon studies (MD = −0.01, 95% CI: [−0.06, 0.04], p = 0.73). In the single-surgeon studies, the BCVA at POM1 was significantly improved in the Yamane group compared to SSF (MD = −0.10, 95% CI: [−0.16, −0.04], p = 0.002). In the multiple-surgeon studies, there was no significant difference in BCVA at POM1 (MD = −0.06, 95% CI: [−0.16, 0.04], p = 0.23). The Yamane group had a shorter surgical duration than SSF in both single-surgeon and multiple-surgeon studies (MD = −24.68, 95% CI: [−35.90, −13.46], p < 0.0001). The ECC, refractive error, and complication rates did not significantly differ amongst all groups. Conclusions: The Yamane technique demonstrated similar long-term visual outcomes and complication rates to the traditional SSF. Visual recovery was significantly faster in the Yamane group in the single-surgeon studies. The operative times were shorter across all Yamane groups. Based on these findings, it is advisable to consider the Yamane technique as a viable, and perhaps preferable, option for patients requiring secondary IOL placement, alongside traditional SSF methods.
- 24 May 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (11) , 3071
Open AccessClinical Outcomes in Scleral Fixation Secondary Intraocular Lens with Yamane versus Suture Techniques: A Systematic Review and Meta-Analysis
Background: The purpose of the study is to compare the visual outcomes and complications of sutured scleral fixation (SSF), a traditional and conservative surgical approach, and the newer and faster Yamane technique for secondary intraocular lens placement. Methods: A literature search was performed on PubMed, Embase, and Scopus on studies published between 1 July 2017 to 29 September 2023. Outcomes analyzed included the final best corrected visual acuity (BCVA) between 3 and 12 months to assess the effectiveness of the procedure, post-operative month (POM) 1 BCVA to assess the speed of visual recovery, endothelial cell count (ECC), absolute refractive error, surgical duration, and complication rates. Additional subgroup analyses were performed based on surgeon experience with the technique. Single-surgeon studies had an average of 26 procedures performed, whereas multiple-surgeon studies averaged only 9 procedures performed; these were then used to delineate surgeon experience. A sample-size weighted mean difference (MD) meta-analysis was performed across all variables using RevMan 5.4.1; p < 0.05 was considered statistically significant. Results: Thirteen studies with 737 eyes were included: 406 eyes were included in the SSF group, and 331 eyes were included in the Yamane group. There was no significant difference in the final BCVA between groups in both the single-surgeon versus multiple-surgeon studies (MD = −0.01, 95% CI: [−0.06, 0.04], p = 0.73). In the single-surgeon studies, the BCVA at POM1 was significantly improved in the Yamane group compared to SSF (MD = −0.10, 95% CI: [−0.16, −0.04], p = 0.002). In the multiple-surgeon studies, there was no significant difference in BCVA at POM1 (MD = −0.06, 95% CI: [−0.16, 0.04], p = 0.23). The Yamane group had a shorter surgical duration than SSF in both single-surgeon and multiple-surgeon studies (MD = −24.68, 95% CI: [−35.90, −13.46], p < 0.0001). The ECC, refractive error, and complication rates did not significantly differ amongst all groups. Conclusions: The Yamane technique demonstrated similar long-term visual outcomes and complication rates to the traditional SSF. Visual recovery was significantly faster in the Yamane group in the single-surgeon studies. The operative times were shorter across all Yamane groups. Based on these findings, it is advisable to consider the Yamane technique as a viable, and perhaps preferable, option for patients requiring secondary IOL placement, alongside traditional SSF methods.
- Open Access
- 15 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (6) , 5636
Heritable Risk and Protective Genetic Components of Glaucoma Medication Non-Adherence
Glaucoma is the leading cause of irreversible blindness, affecting 76 million globally. It is characterized by irreversible damage to the optic nerve. Pharmacotherapy manages intraocular pressure (IOP) and slows disease progression. However, non-adherence to glaucoma medications remains problematic, with 41–71% of patients being non-adherent to their prescribed medication. Despite substantial investment in research, clinical effort, and patient education protocols, non-adherence remains high. Therefore, we aimed to determine if there is a substantive genetic component behind patients’ glaucoma medication non-adherence. We assessed glaucoma medication non-adherence with prescription refill data from the Marshfield Clinic Healthcare System’s pharmacy dispensing database. Two standard measures were calculated: the medication possession ratio (MPR) and the proportion of days covered (PDC). Non-adherence on each metric was defined as less than 80% medication coverage over 12 months. Genotyping was done using the Illumina HumanCoreExome BeadChip in addition to exome sequencing on the 230 patients (1) to calculate the heritability of glaucoma medication non-adherence and (2) to identify SNPs and/or coding variants in genes associated with medication non-adherence. Ingenuity pathway analysis (IPA) was utilized to derive biological meaning from any significant genes in aggregate. Over 12 months, 59% of patients were found to be non-adherent as measured by the MPR80, and 67% were non-adherent as measured by the PDC80. Genome-wide complex trait analysis (GCTA) suggested that 57% (MPR80) and 48% (PDC80) of glaucoma medication non-adherence could be attributed to a genetic component. Missense mutations in TTC28, KIAA1731, ADAMTS5, OR2W3, OR10A6, SAXO2, KCTD18, CHCHD6, and UPK1A were all found to be significantly associated with glaucoma medication non-adherence by whole exome sequencing after Bonferroni correction (p < 10−3) (PDC80). While missense mutations in TINAG, CHCHD6, GSTZ1, and SEMA4G were found to be significantly associated with medication non-adherence by whole exome sequencing after Bonferroni correction (p < 10−3) (MPR80). The same coding SNP in CHCHD6 which functions in Alzheimer’s disease pathophysiology was significant by both measures and increased risk for glaucoma medication non-adherence by three-fold (95% CI, 1.62–5.8). Although our study was underpowered for genome-wide significance, SNP rs6474264 within ZMAT4 (p = 5.54 × 10–6) was found to be nominally significant, with a decreased risk for glaucoma medication non-adherence (OR, 0.22; 95% CI, 0.11–0.42)). IPA demonstrated significant overlap, utilizing, both standard measures including opioid signaling, drug metabolism, and synaptogenesis signaling. CREB signaling in neurons (which is associated with enhancing the baseline firing rate for the formation of long-term potentiation in nerve fibers) was shown to have protective associations. Our results suggest a substantial heritable genetic component to glaucoma medication non-adherence (47–58%). This finding is in line with genetic studies of other conditions with a psychiatric component (e.g., post-traumatic stress disorder (PTSD) or alcohol dependence). Our findings suggest both risk and protective statistically significant genes/pathways underlying glaucoma medication non-adherence for the first time. Further studies investigating more diverse populations with larger sample sizes are needed to validate these findings.
- 15 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (6) , 5636
Open AccessHeritable Risk and Protective Genetic Components of Glaucoma Medication Non-Adherence
Glaucoma is the leading cause of irreversible blindness, affecting 76 million globally. It is characterized by irreversible damage to the optic nerve. Pharmacotherapy manages intraocular pressure (IOP) and slows disease progression. However, non-adherence to glaucoma medications remains problematic, with 41–71% of patients being non-adherent to their prescribed medication. Despite substantial investment in research, clinical effort, and patient education protocols, non-adherence remains high. Therefore, we aimed to determine if there is a substantive genetic component behind patients’ glaucoma medication non-adherence. We assessed glaucoma medication non-adherence with prescription refill data from the Marshfield Clinic Healthcare System’s pharmacy dispensing database. Two standard measures were calculated: the medication possession ratio (MPR) and the proportion of days covered (PDC). Non-adherence on each metric was defined as less than 80% medication coverage over 12 months. Genotyping was done using the Illumina HumanCoreExome BeadChip in addition to exome sequencing on the 230 patients (1) to calculate the heritability of glaucoma medication non-adherence and (2) to identify SNPs and/or coding variants in genes associated with medication non-adherence. Ingenuity pathway analysis (IPA) was utilized to derive biological meaning from any significant genes in aggregate. Over 12 months, 59% of patients were found to be non-adherent as measured by the MPR80, and 67% were non-adherent as measured by the PDC80. Genome-wide complex trait analysis (GCTA) suggested that 57% (MPR80) and 48% (PDC80) of glaucoma medication non-adherence could be attributed to a genetic component. Missense mutations in TTC28, KIAA1731, ADAMTS5, OR2W3, OR10A6, SAXO2, KCTD18, CHCHD6, and UPK1A were all found to be significantly associated with glaucoma medication non-adherence by whole exome sequencing after Bonferroni correction (p < 10−3) (PDC80). While missense mutations in TINAG, CHCHD6, GSTZ1, and SEMA4G were found to be significantly associated with medication non-adherence by whole exome sequencing after Bonferroni correction (p < 10−3) (MPR80). The same coding SNP in CHCHD6 which functions in Alzheimer’s disease pathophysiology was significant by both measures and increased risk for glaucoma medication non-adherence by three-fold (95% CI, 1.62–5.8). Although our study was underpowered for genome-wide significance, SNP rs6474264 within ZMAT4 (p = 5.54 × 10–6) was found to be nominally significant, with a decreased risk for glaucoma medication non-adherence (OR, 0.22; 95% CI, 0.11–0.42)). IPA demonstrated significant overlap, utilizing, both standard measures including opioid signaling, drug metabolism, and synaptogenesis signaling. CREB signaling in neurons (which is associated with enhancing the baseline firing rate for the formation of long-term potentiation in nerve fibers) was shown to have protective associations. Our results suggest a substantial heritable genetic component to glaucoma medication non-adherence (47–58%). This finding is in line with genetic studies of other conditions with a psychiatric component (e.g., post-traumatic stress disorder (PTSD) or alcohol dependence). Our findings suggest both risk and protective statistically significant genes/pathways underlying glaucoma medication non-adherence for the first time. Further studies investigating more diverse populations with larger sample sizes are needed to validate these findings.
- 1 April 2022
- Published by Elsevier in Ophthalmology Retina
- Vol. 6 (4) , 328-330
Effect of Low-dose Intravitreal Bevacizumab and Ranibizumab on Regression and Late Reactivation in Retinopathy of Prematurity in the Treatment-Naïve Eyes
- 1 April 2022
- Published by Elsevier in Ophthalmology Retina
- Vol. 6 (4) , 328-330
Effect of Low-dose Intravitreal Bevacizumab and Ranibizumab on Regression and Late Reactivation in Retinopathy of Prematurity in the Treatment-Naïve Eyes
- Open Access
- 31 December 2021
- Published by Open Exploration Publishing in Exploration of Medicine
- Vol. 2 (6) , 527-543
A global genetic epidemiological review of pseudoexfoliation syndrome
Pseudoexfoliation (PXF) syndrome is an important public health concern requiring individual population level analysis. Disease prevalence differs by geographic location and ethnicity, and has environmental, demographic, genetic, and molecular risk factors have been demonstrated. Epidemiological factors that have been associated with PXF include age, sex, environmental factors, and diet. Genetic and molecular components have also been identified that are associated with PXF. Underserved populations are often understudied within scientific research, including research about eye disease such as PXF, contributing to the persistence of health disparities within these populations. In each population, PXF needs may be different, and by having research that identifies individual population needs about PXF, the resources in that population can be more efficiently utilized. Otherwise, PXF intervention and care management based only on the broadest level of understanding may continue to exacerbate health disparities in populations disproportionally burdened by PXF.
- 31 December 2021
- Published by Open Exploration Publishing in Exploration of Medicine
- Vol. 2 (6) , 527-543
Open AccessA global genetic epidemiological review of pseudoexfoliation syndrome
Pseudoexfoliation (PXF) syndrome is an important public health concern requiring individual population level analysis. Disease prevalence differs by geographic location and ethnicity, and has environmental, demographic, genetic, and molecular risk factors have been demonstrated. Epidemiological factors that have been associated with PXF include age, sex, environmental factors, and diet. Genetic and molecular components have also been identified that are associated with PXF. Underserved populations are often understudied within scientific research, including research about eye disease such as PXF, contributing to the persistence of health disparities within these populations. In each population, PXF needs may be different, and by having research that identifies individual population needs about PXF, the resources in that population can be more efficiently utilized. Otherwise, PXF intervention and care management based only on the broadest level of understanding may continue to exacerbate health disparities in populations disproportionally burdened by PXF.
- Open Access
- 6 July 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (14) , 7231
Pseudoexfoliation and Cataract Syndrome Associated with Genetic and Epidemiological Factors in a Mayan Cohort of Guatemala
The Mayan population of Guatemala is understudied within eye and vision research. Studying an observational homogenous, geographically isolated population of individuals seeking eye care may identify unique clinical, demographic, environmental and genetic risk factors for blinding eye disease that can inform targeted and effective screening strategies to achieve better and improved health care distribution. This study served to: (a) identify the ocular health needs within this population; and (b) identify any possible modifiable risk factors contributing to disease pathophysiology within this population. We conducted a cross-sectional study with 126 participants. Each participant completed a comprehensive eye examination, provided a blood sample for genetic analysis, and received a structured core baseline interview for a standardized epidemiological questionnaire at the Salama Lions Club Eye Hospital in Salama, Guatemala. Interpreters were available for translation to the patients’ native dialect, to assist participants during their visit. We performed a genome-wide association study for ocular disease association on the blood samples using Illumina’s HumanOmni2.5-8 chip to examine single nucleotide polymorphism SNPs in this population. After implementing quality control measures, we performed adjusted logistic regression analysis to determine which genetic and epidemiological factors were associated with eye disease. We found that the most prevalent eye conditions were cataracts (54.8%) followed by pseudoexfoliation syndrome (PXF) (24.6%). The population with both conditions was 22.2%. In our epidemiological analysis, we found that eye disease was significantly associated with advanced age. Cataracts were significantly more common among those living in the 10 districts with the least resources. Furthermore, having cataracts was associated with a greater likelihood of PXF after adjusting for both age and sex. In our genetic analysis, the SNP most nominally significantly associated with PXF lay within the gene KSR2 (p < 1 × 10−5). Several SNPs were associated with cataracts at genome-wide significance after adjusting for covariates (p < 5 × 10−8). About seventy five percent of the 33 cataract-associated SNPs lie within 13 genes, with the majority of genes having only one significant SNP (5 × 10−8). Using bioinformatic tools including PhenGenI, the Ensembl genome browser and literature review, these SNPs and genes have not previously been associated with PXF or cataracts, separately or in combination. This study can aid in understanding the prevalence of eye conditions in this population to better help inform public health planning and the delivery of quality, accessible, and relevant health and preventative care within Salama, Guatemala.
- 6 July 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (14) , 7231
Open AccessPseudoexfoliation and Cataract Syndrome Associated with Genetic and Epidemiological Factors in a Mayan Cohort of Guatemala
The Mayan population of Guatemala is understudied within eye and vision research. Studying an observational homogenous, geographically isolated population of individuals seeking eye care may identify unique clinical, demographic, environmental and genetic risk factors for blinding eye disease that can inform targeted and effective screening strategies to achieve better and improved health care distribution. This study served to: (a) identify the ocular health needs within this population; and (b) identify any possible modifiable risk factors contributing to disease pathophysiology within this population. We conducted a cross-sectional study with 126 participants. Each participant completed a comprehensive eye examination, provided a blood sample for genetic analysis, and received a structured core baseline interview for a standardized epidemiological questionnaire at the Salama Lions Club Eye Hospital in Salama, Guatemala. Interpreters were available for translation to the patients’ native dialect, to assist participants during their visit. We performed a genome-wide association study for ocular disease association on the blood samples using Illumina’s HumanOmni2.5-8 chip to examine single nucleotide polymorphism SNPs in this population. After implementing quality control measures, we performed adjusted logistic regression analysis to determine which genetic and epidemiological factors were associated with eye disease. We found that the most prevalent eye conditions were cataracts (54.8%) followed by pseudoexfoliation syndrome (PXF) (24.6%). The population with both conditions was 22.2%. In our epidemiological analysis, we found that eye disease was significantly associated with advanced age. Cataracts were significantly more common among those living in the 10 districts with the least resources. Furthermore, having cataracts was associated with a greater likelihood of PXF after adjusting for both age and sex. In our genetic analysis, the SNP most nominally significantly associated with PXF lay within the gene KSR2 (p < 1 × 10−5). Several SNPs were associated with cataracts at genome-wide significance after adjusting for covariates (p < 5 × 10−8). About seventy five percent of the 33 cataract-associated SNPs lie within 13 genes, with the majority of genes having only one significant SNP (5 × 10−8). Using bioinformatic tools including PhenGenI, the Ensembl genome browser and literature review, these SNPs and genes have not previously been associated with PXF or cataracts, separately or in combination. This study can aid in understanding the prevalence of eye conditions in this population to better help inform public health planning and the delivery of quality, accessible, and relevant health and preventative care within Salama, Guatemala.
- Open Access
- 1 May 2021
- Published by Elsevier in Ophthalmology
- Vol. 128 (5) , 780
Iris Infiltration as a Sign of Relapse in a Child with Chronic Myeloid Leukemia
- 1 May 2021
- Published by Elsevier in Ophthalmology
- Vol. 128 (5) , 780
Open AccessIris Infiltration as a Sign of Relapse in a Child with Chronic Myeloid Leukemia
- 9 June 2020
- Published by BMJ in BMJ Case Reports
- Vol. 13 (6) , e233394
Retrobulbar chlorpromazine injection in a child with gliosarcoma invasion into the orbits
This paper has two main purposes: (1) to report a rare case of paediatric gliosarcoma that invaded the surrounding orbit and (2) to demonstrate chlorpromazine injection as a potential treatment option for blind, painful eye caused by tumour invasion. A 12-year-old man who presented with headaches was found to have glioblastoma multiforme and it was excised and treated with radiation and chemotherapy. Seven months later, the tumour recurred as gliosarcoma, a rare variant of glioblastoma multiforme containing distinct gliomatous and sarcomatous components. In spite of treatment, the tumour progressed and eventually invaded into the right orbit. He subsequently developed a proptotic, blind, painful eye and was treated with retrobulbar chlorpromazine injection, which provided immediate symptomatic relief.
- 9 June 2020
- Published by BMJ in BMJ Case Reports
- Vol. 13 (6) , e233394
Retrobulbar chlorpromazine injection in a child with gliosarcoma invasion into the orbits
This paper has two main purposes: (1) to report a rare case of paediatric gliosarcoma that invaded the surrounding orbit and (2) to demonstrate chlorpromazine injection as a potential treatment option for blind, painful eye caused by tumour invasion. A 12-year-old man who presented with headaches was found to have glioblastoma multiforme and it was excised and treated with radiation and chemotherapy. Seven months later, the tumour recurred as gliosarcoma, a rare variant of glioblastoma multiforme containing distinct gliomatous and sarcomatous components. In spite of treatment, the tumour progressed and eventually invaded into the right orbit. He subsequently developed a proptotic, blind, painful eye and was treated with retrobulbar chlorpromazine injection, which provided immediate symptomatic relief.
- Open Access
- 1 September 2019
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 137 (9) , 1015-1020
Gender Differences in Case Volume Among Ophthalmology Residents
The Accreditation Council for Graduate Medical Education (ACGME) requires that ophthalmology residency programs enable residents to perform a minimum number of procedural cases and ensure that their trainees have “equivalent educational opportunities.”1(p16) Prior research on cataract surgical training based on data from 1999 to 2002 found that surgical competency improves with increasing case volumes, even beyond the minimum number of required cataract operations for graduation (currently 86).2 The rate of intraoperative complications continues to decrease and operating efficiency continues to increase at case volumes beyond 160. More recent studies3,4 have also found that operating efficiency continues to improve after residents have completed more than 100 cataract cases. These findings suggest the importance of performing a sufficient number of cases during training to graduate as competent ophthalmic surgeons, which may be higher than the current ACGME minimum requirement of 86 cases.
- 1 September 2019
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 137 (9) , 1015-1020
Open AccessGender Differences in Case Volume Among Ophthalmology Residents
The Accreditation Council for Graduate Medical Education (ACGME) requires that ophthalmology residency programs enable residents to perform a minimum number of procedural cases and ensure that their trainees have “equivalent educational opportunities.”1(p16) Prior research on cataract surgical training based on data from 1999 to 2002 found that surgical competency improves with increasing case volumes, even beyond the minimum number of required cataract operations for graduation (currently 86).2 The rate of intraoperative complications continues to decrease and operating efficiency continues to increase at case volumes beyond 160. More recent studies3,4 have also found that operating efficiency continues to improve after residents have completed more than 100 cataract cases. These findings suggest the importance of performing a sufficient number of cases during training to graduate as competent ophthalmic surgeons, which may be higher than the current ACGME minimum requirement of 86 cases.
- 1 October 2018
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 22 (5) , 340-343
The effect of oral statin therapy on strabismus in patients with thyroid eye disease
- 1 October 2018
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 22 (5) , 340-343
The effect of oral statin therapy on strabismus in patients with thyroid eye disease